title: Pharmacological profile of novel cyclic analogs of 2-amino-7-phosphonoheptanoic acid.
authors.affiliation: Nova Pharmaceutical Corporation, CNS Pharmacology, Baltimore, Maryland 21224.
authors.forename: J W
authors.initials: JW
authors.lastname: Ferkany
authors.forename: D J
authors.initials: DJ
authors.lastname: Kyle
authors.forename: W P
authors.initials: WP
authors.lastname: Ellenberger
authors.forename: B A
authors.initials: BA
authors.lastname: Narayanan
authors.forename: S R
authors.initials: SR
authors.lastname: Ellenberger
authors.forename: R
authors.initials: R
authors.lastname: Hudkins
authors.forename: M E
authors.initials: ME
authors.lastname: Guzewska
authors.forename: W J
authors.initials: WJ
authors.lastname: Rzeszotarski
authors.forename: L
authors.initials: L
authors.lastname: Conti
authors.forename: R
authors.initials: R
authors.lastname: Patch
mesh_terms: D015763:2-Amino-5-phosphonovalerate / Q000031:analogs & derivatives*; D000596:Amino Acids / Q000494:pharmacology* / Q000633:toxicity; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology* / Q000633:toxicity; D001921:Brain / Q000187:drug effects* / Q000503:physiopathology; D004305:Dose-Response Relationship, Drug; D004597:Electroshock; D008297:Male; D051379:Mice; D016202:N-Methylaspartate / Q000494:pharmacology; D010433:Pentylenetetrazole / Q000494:pharmacology; D016194:Receptors, N-Methyl-D-Aspartate / Q000187:drug effects* / Q000502:physiology; D012640:Seizures / Q000139:chemically induced / Q000503:physiopathology*; D013329:Structure-Activity Relationship
chemical_list: D000596:Amino Acids; D000927:Anticonvulsants; D016194:Receptors, N-Methyl-D-Aspartate; C060212:NPC 12626; D016202:N-Methylaspartate; D015763:2-Amino-5-phosphonovalerate; C031231:2-amino-7-phosphonoheptanoic acid; D010433:Pentylenetetrazole